Correspondence 0001493152-23-027300 from ENvue Medical, Inc. (FEED)

ENvue Medical, Inc.
Date: Aug. 9, 2023 · CIK: 0001326706 · Accession: 0001493152-23-027300

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-273574

Date

Aug. 9, 2023

Author

Chief

Form

CORRESP

Company

ENvue Medical, Inc.

Letter

NanoVibronix, Inc.

Executive Boulevard

Elmsford, New York 10523

August 9, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Industrial Applications and Services

Securities and Exchange Commission

Washington, D.C. 20549

Attention: Abby Adams

Re: NanoVibronix, Inc.

Registration Statement on Form S-3

Filed on August 1, 2023

File No. 333-273574 (the “Registration Statement”)

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, NanoVibronix, Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement, so that it may become effective at 4:30 p.m., Eastern Time, on August 11, 2023, or as soon thereafter as practicable.

Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Jayun Koo, Esq. at (212) 835-4823.

Very
truly yours,
NANOVIBRONIX,
INC.

Show Raw Text

CORRESP
1
filename1.htm

NanoVibronix,
Inc.

525
Executive Boulevard

Elmsford,
New York 10523

August
9, 2023

VIA
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

Office
of Industrial Applications and Services

Securities
and Exchange Commission

Washington,
D.C. 20549

Attention:
Abby Adams

    Re:
    NanoVibronix,
    Inc.

    Registration
    Statement on Form S-3

    Filed
    on August 1, 2023

    File
    No. 333-273574 (the “Registration Statement”)

Request
for Acceleration

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under
the Securities Act of 1933, as amended, NanoVibronix, Inc. (the “Company”) hereby respectfully requests acceleration
of the effective date of the Registration Statement, so that it may become effective at 4:30 p.m., Eastern Time, on August 11, 2023,
or as soon thereafter as practicable.

Should
any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes
and Boone, LLP, attention: Jayun Koo, Esq. at (212) 835-4823.

    Very
    truly yours,

    NANOVIBRONIX,
    INC.

    By:
    /s/
    Brian Murphy

    Brian
    Murphy

    Chief
    Executive Officer

    cc:
    Jayun
    Koo, Esq., Haynes and Boone, LLP

SecProbe.io